ADM: The Sales Quota Behind the Price Promise

ADM lysine price fixing joined an agreement on prices to an agreement on how much each producer could sell. The criminal court’s account of the cartel describes rivals reporting monthly sales and promising to buy from one another if their sales exceeded their allotted shares. Customers could still choose a supplier. Behind that choice, the suppliers were protecting each other’s business. An executive inside ADM helped the FBI record the arrangement as it operated.

Archer Daniels Midland was an agricultural processing company based in Decatur, Illinois. The Seventh Circuit’s opinion describes ADM’s corporate guilty plea and the separate jury convictions of three company executives.

The court opened with a former ADM president’s description of the company’s relationship with the people buying its products:

The sales arrangement gave that attitude a practical form. A customer bargaining for a lower price was a problem the producers wanted to solve together. Feed makers paid the price the cartel held up.

A Feed Ingredient Sold on Price

Lysine is an amino acid added to animal feed to support growth. The court’s industry account describes a fermentation process: microorganisms consume nutrients, principally sugar, and produce lysine that manufacturers harvest and sell to feed makers. Those businesses add it to feed sold to farmers raising chickens and pigs.

The production process was delicate, but the finished product was interchangeable. Buyers chose largely on price. The price of substitutes such as soy or fish meal also mattered. That gave a feed purchaser reasons to compare offers, and gave a producer a reason to undercut a rival to win the order.

Before ADM entered, Ajinomoto, Kyowa Hakko and Miwon supplied the market. ADM began producing lysine in 1991 at its large Illinois plant, while Cheil Jedang also entered the business. The new capacity set off a price war.

For the buyer, competing production capacity meant suppliers fighting over the sale. For the producers described in the criminal opinion, it became a reason to negotiate with one another.

Meetings to Raise Prices, an Agenda to Hide Them

The lysine producers began negotiating prices and sales allocations at a June 1992 meeting in Mexico City. According to the court’s account, ADM, Ajinomoto and Kyowa agreed on staged price increases, but disagreed over how much of the market each company should receive.

ADM wanted a share that reflected its new capacity. Ajinomoto disputed both the size of that demand and ADM’s ability to produce so much. ADM subsequently invited Ajinomoto representatives to tour the Decatur plant. Manufacturing capacity was part of the bargaining between supposed competitors.

At the October meeting in Paris, the producers used a false agenda to disguise their purpose. It listed animal rights and the environment. Internal Ajinomoto documents instead described checking the current price, the market’s reaction and the future price schedule. The producers later created a fictitious trade association to give their meetings cover.

Agreeing on a price still left each company with a reason to sell below it. As the criminal opinion recounts, a producer could win more business by undercutting while its rivals held their prices. Rivals then had to match the lower offer or lose the customer. Prices fell again in the spring of 1993.

The cartel’s problem was competition surviving inside its own agreement.

Sales Quotas Took the Competition Out of Customer Choice

The sales-volume agreement addressed that problem by assigning each producer a share and requiring purchases between rivals to correct excess sales. In the court’s explanation of the arrangement, customers could keep choosing their suppliers while the cartel settled the allocation among its members.

The breakthrough came at an October 1993 meeting in Irvine, California. An ADM executive threatened to flood the market unless the companies reached a volume agreement that allowed ADM to increase its sales. Senior management from ADM and Ajinomoto reached a deal that also divided expected market growth.

The allocation assigned ADM 67,000 tons and Ajinomoto 84,000 tons for the following year. Subsequent meetings in Tokyo worked through the operating details. Each producer would report its monthly sales by telephone to an Ajinomoto executive. A producer that exceeded its allocation would buy enough lysine from producers that fell short to bring the shares back into line.

Selling beyond the agreed share therefore came with an obligation to buy from a rival. A producer that fell short had the other cartel members’ purchase commitment behind it. An Ajinomoto executive explained the incentive in testimony quoted by the court:

Customer negotiations attracted their own attention. The court describes ADM’s concern that buyers would claim to have cheaper offers from other producers. Executives discussed a rapid way to check those offers with one another. ADM’s centralized pricing also became a model its executive urged Ajinomoto to follow.

The arrangement reached into ordinary sales work: who could approve a price, how sales were reported, and what happened when a customer sought a better offer. The buyer saw several suppliers. The suppliers were discussing how to stop that choice from lowering the price.

At a meeting in Atlanta in January 1995, the producers compared annual sales with the agreed allocations. Each had finished fairly close to its allotted volume. A major poultry exposition supplied cover for their presence in the same city. The court describes one further cartel meeting before FBI raids on ADM and Heartland Lysine ended the arrangement.

Cooperation Began With a False Sabotage Story

The cooperating insider was ADM’s bioproducts president, whose responsibilities included lysine production, sales and distribution. The government’s brief in the criminal case identifies that operating role. He attended the early cartel meetings before becoming an FBI cooperating witness.

The court’s account explains the unlikely path to that cooperation. The executive committed embezzlement through phony outside-company invoices and continued it while cooperating with the FBI. He invented a story that Ajinomoto had planted a saboteur in ADM’s lysine facility. The plant’s early fermentation difficulties helped make the story believable.

ADM management sought government assistance, bringing the FBI into the supposed sabotage and extortion matter. When an agent proposed recording the expected extortion call, the executive knew there would be no call. He confessed the fabrication and agreed to help investigate price fixing.

The recordings gave investigators something beyond the cooperating executive’s account: they could hear other participants discussing the agreement themselves.

What the Recordings and Business Records Showed

The FBI supplied equipment and instructions, met with the cooperating executive and reviewed recordings. Agents also videotaped cartel meetings, sometimes posing as hotel staff. The criminal opinion describes an operation directed by investigators.

For a reader considering evidence in a present-day case, recording and access questions belong in the individual discussion with our whistleblower experts.

The recordings captured the chain of command as well as the meetings. The jury heard a senior ADM executive coaching a subordinate before a cartel discussion. It saw senior management settle the volume dispute that other executives had been unable to resolve. Reports back to management, instructions before meetings and the threat to flood the market connected authority inside ADM to the agreement outside it.

Documents supplied another view. After the raids, Ajinomoto destroyed cartel records in its Tokyo office. An executive had overlooked copies stored at home and later turned them over to the FBI. They included internal reports of the Mexico City and Paris meetings. Those reports described the business the false agenda concealed.

In the lysine case, investigators could compare the producers’ reported sales with the conversations about the shares they intended to maintain. The monthly totals showed performance against the arrangement. The recordings and meeting reports showed why those totals mattered to the companies.

The criminal opinion also describes a model for the lysine scheme in ADM’s separate citric-acid conspiracy. Executives carried over trade-association cover and the lesson that controlling prices meant allocating sales.

Would This Have Qualified Under Today’s Reporting Routes?

Our whistleblower experts assess whether a comparable cartel report could qualify for a reward under the Antitrust Division and Postal Service rewards agreement, effective May 7, 2025. We work through the evidence and any Postal Service connection with you.

If lysine pricing reached government purchases, we examine the claims and representations used to obtain payment. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

You Know Who Set the Sales Target

Our whistleblower experts want to understand how an ADM sales quota affected the price promise and the figures exchanged with competitors.